Multicenter, cross‐sectional study of the costs of illness and cost‐driving factors in adult patients with epilepsy

Direct and indirect costs and cost-driving factors of Tuberous sclerosis complex in children, adolescents, and caregivers: a multicenter cohort study

(2021) Janina Grau et al.   Orphanet Journal of Rare Diseases

Direct and indirect costs and cost-driving factors in adults with tuberous sclerosis complex: a multicenter cohort study and a review of the literature

(2021) Johann Philipp Zöllner et al.   Orphanet Journal of Rare Diseases

Costs of Epilepsy in Austria: Unemployment as a primary driving factor

(2021) S. Pirker et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

The economic burden of newly diagnosed epilepsy in Spain

(2021) Manuel Quintana et al.   EPILEPSY & BEHAVIOR

Health-related quality of life in children and adolescents with tuberous sclerosis complex and their caregivers: A multicentre cohort study from Germany

(2021) Laurent M. Willems et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

The costs of epilepsy in Australia: A productivity-based analysis

(2020) Emma Foster et al.   NEUROLOGY

Burden-of-illness and cost-driving factors in Dravet syndrome patients and carers: A prospective, multicenter study from Germany

(2019) Adam Strzelczyk et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Counseling and social work for people with epilepsy in Germany: A cross-sectional multicenter study on demand, frequent content, patient satisfaction, and burden-of-disease

(2019) Laurent M. Willems et al.   EPILEPSY & BEHAVIOR

General Trends in Prices and Prescription Patterns of Anticonvulsants in Germany between 2000 and 2017: Analysis of National and Cohort-Based Data

(2019) Laurent M. Willems et al.   Applied Health Economics and Health Policy

Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): A randomized controlled trial

(2018) Loes A.M. Leenen et al.   EPILEPSY & BEHAVIOR

Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 — A ten-year overview

(2018) Laurent M. Willems et al.   EPILEPSY & BEHAVIOR

Costs of Illness in Chronic Inflammatory Demyelinating Polyneuropathy in Germany

(2018) David Mengel et al.   MUSCLE & NERVE

Instruction manual for the ILAE 2017 operational classification of seizure types

(2017) Robert S. Fisher et al.   EPILEPSIA

Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology

(2017) Robert S. Fisher et al.   EPILEPSIA

ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology

(2017) Ingrid E. Scheffer et al.   EPILEPSIA

New insights into the burden and costs of multiple sclerosis in Europe: Results for Germany

(2017) Peter Flachenecker et al.   Multiple Sclerosis Journal

New insights into the burden and costs of multiple sclerosis in Europe: Results for Germany

(2017) Peter Flachenecker et al.   Multiple Sclerosis Journal

The Burden of Severely Drug-Refractory Epilepsy: A Comparative Longitudinal Evaluation of Mortality, Morbidity, Resource Use, and Cost Using German Health Insurance Data

(2017) Adam Strzelczyk et al.   Frontiers in Neurology

Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany

(2016) Lena-Marie Kortland et al.   EPILEPSIA

Premature mortality of epilepsy in low- and middle-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy

(2016) Francis Levira et al.   EPILEPSIA

Neurologist adherence to clinical practice guidelines and costs in patients with newly diagnosed and chronic epilepsy in Germany

(2016) Adam Strzelczyk et al.   EPILEPSY & BEHAVIOR

The economic impact of epilepsy: a systematic review

(2015) Katharina Allers et al.   BMC Neurology

The direct cost of epilepsy in the United States: A systematic review of estimates

(2015) Charles E. Begley et al.   EPILEPSIA

Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany

(2015) Janna Riechmann et al.   EPILEPSIA

Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany

(2013) Adam Strzelczyk et al.   EPILEPSY & BEHAVIOR

Healthcare utilization and costs in adults with stable and uncontrolled epilepsy

(2013) Joyce A. Cramer et al.   EPILEPSY & BEHAVIOR

Personalized Medicine and the Role of Health Economics and Outcomes Research: Issues, Applications, Emerging Trends, and Future Research

(2013) John C. O’Donnell   VALUE IN HEALTH

Evaluation of health-care utilization among adult patients with epilepsy in Germany

(2012) Adam Strzelczyk et al.   EPILEPSY & BEHAVIOR

Predictors of health-related quality of life and costs in adults with epilepsy: A systematic review

(2011) Rod S. Taylor et al.   EPILEPSIA

Driving cost factors in adult outpatients with refractory epilepsy: A daily clinical practice in clinics of neurology in Spain

(2008) Pilar Peña et al.   EPILEPSY RESEARCH

Cost of Epilepsy

(2008) Adam Strzelczyk et al.   PHARMACOECONOMICS

German Recommendations on Health Economic Evaluation: Third and Updated Version of the Hanover Consensus

(2008) J.-Matthias Graf von der Schulenburg et al.   VALUE IN HEALTH